The Joel Bieber Firm is currently considering the pursuit of claims against the following medical device manufacturers, relating to Transvaginal Mesh Failures: Johnson & Johnson, Boston Scientific, American Systems and Bard.

The FDA has issued a warning relating to these surgical mesh systems that were used during a wide variety of surgical procedures that were performed to repair weakened or damaged tissue. The FDA warning is here, which outlines the information; what you should do and the complications from Pelvic Organ Prolapse.

Vaginal mesh erosion is the most common mesh-related complication and reportedly occurs in about 10% of patients within 12 months of surgery. Other adverse effects that have been reported include: infection, pain, urinary problems, recurrence of prolapse and/or incontinence; bowel, bladder and blood vessel perforation and erosion through vaginal epithelium.

On July 13, 2011, the FDA issued a safety warning to health-care providers who use surgical mesh in POP or SUO repairs. To date, there have been approximately 4000 reports of adverse events.

For more information, please fill out the following Joel Bieber information form. As we collect information, we will be determining potential considerations in the pursuit of the possible claims against these medical device makers.

For More Information: “Warning About Surgical Mesh Devices in Women